Chugai Pharmaceutical Co., Ltd.
MarketLine (a Datamonitor Company)
08 Apr 2014
Available for Immediate Download
Chugai Pharmaceutical Co., Ltd. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company. Features: - Detailed information on Chugai Pharmaceutical Co., Ltd. required for business and competitor intelligence needs - A study of the major internal and external factors affecting Chugai Pharmaceutical Co., Ltd. in the form of a SWOT analysis - An in-depth view of the business model of Chugai Pharmaceutical Co., Ltd. including a breakdown and examination of key business segments - Intelligence on Chugai Pharmaceutical Co., Ltd.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Chugai Pharmaceutical Co., Ltd., such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Chugai Pharmaceutical Co., Ltd. (Chugai or 'the company'), the Japanese subsidiary of the Roche Group, is engaged in biopharmaceutical research and development. It produces antibody drugs, focused in three major areas, oncology, renal diseases and bone an Reasons to Purchase: - Gain understanding of Chugai Pharmaceutical Co., Ltd. and the factors that influence its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Chugai Pharmaceutical Co., Ltd. as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Chugai Pharmaceutical Co., Ltd.’s business structure, strategy and prospects